# US 2011/0301210 A1 · Use of pramipexole to treat amyotrophic lateral sclerosis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0301210 A1
- Document ID: US20110301210A1
- Status: Published application
- Kind: A1
- Application number: 13/195,552
- Filed: 2011-08-01
- Published: 2011-12-08
- Earliest claimed: 2001-12-11
- Assignees: University of Virginia Patent Foundation
- Inventors: James P. Bennett, JR.
- Web page: https://patentgrep.com/patent/US20110301210A1

## CPC

- A61K 31/428: condensed with carbocyclic rings
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 21/00: Drugs for disorders of the muscular or neuromuscular system
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/14: for treating abnormal movements, e.g. chorea, dyskinesia
- A61P 25/16: Anti-Parkinson drugs
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 39/06: Free radical scavengers or antioxidants
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The present invention is directed to compositions comprising pramipexole and the use of such compositions to treat neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). As shown in FIG. 6B the mean +/−SEM serum 2,3-DHBA levels for the 12 ALS participants decreased significantly after pramipexole treatment.

## Claims

### Claim 1

A method of treating ALS patients, said method comprising the step of administering to said patient a composition comprising a tetrahydrobenthiazole having the general structure:
wherein R1, R2, R3, and R4, are independently selected from the group consisting of H and C1-C3 alkyl.

### Claim 2 (depends on 1)

The method of claim 1 wherein R1, R2, and R4, are H and R3 is C1-C3 alkyl.

### Claim 3 (depends on 1)

The method of claim 1 wherein said tetrahydrobenthiazole is pramipexole.

### Claim 4 (depends on 3)

The method of claim 3 wherein greater than 90% of the pramipexole in said composition is R(+) 2-amino-4,5,6,7-tetrahydro-6-propylaminobenzathiazole

### Claim 5

A method for enhancing the bioelectric potential (ΔΨ) across mitochondrial membranes of cells with impaired mitochondrial energy production, said method comprising the step of contacting said cells with a composition comprising a tetrahydrobenthiazole having the general structure
wherein R1, R2, R3, and R4, are independently selected from the group consisting of H and C1-C3 alkyl.

### Claim 6 (depends on 5)

The method of claim 5 wherein said tetrahydrobenthiazole is pramipexole.

### Claim 7 (depends on 6)

The method of claim 6 wherein greater than 90% of the pramipexole compound is R(+) 2-amino-4,5,6,7-tetrahydro-6-propylaminobenzathiazole.

### Claim 8

A method of reducing oxidative stress in an ALS patient, said method comprising the step of administering to said patient a composition comprising a tetrahydrobenthiazole having the general structure:
wherein R1, R2, and R3 are H and R4 is C1-C3 alkyl.

### Claim 9 (depends on 8)

The method of claim 8 wherein said tetrahydrobenthiazole is pramipexole.

### Claim 10 (depends on 9)

The method of claim 9 wherein said pramipexole is R(+) 2-amino-4,5,6,7-tetrahydro-6-propylaminobenzathiazole.
